5-(m-Tolyloxy)pyrimidin-2(1H)-one

Catalog No. :
ACIVQY671
CAS No. :
41964-07-2
Molecular Formula :
C11H10N2O2
Molecular Weight :
202.21

IUPAC Name:5-(m-tolyloxy)pyrimidin-2(1H)-one

5-(m-Tolyloxy)pyrimidin-2(1H)-one structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
10mg99%$60.00Login to see priceInquiryInquiry
25mg99%$108.00Login to see priceIn stockInquiry
50mg99%$163.00Login to see priceIn stockInquiry
100mg99%$245.00Login to see priceIn stockInquiry
250mg99%$611.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name5-(m-Tolyloxy)pyrimidin-2(1H)-one
IUPAC Name5-(m-tolyloxy)pyrimidin-2(1H)-one
MDL No.MFCD00866900
Molecular FormulaC11H10N2O2
Molecular Weight202.21
SMILESO=C1N=CC(OC2=CC=CC(C)=C2)=CN1
InChI KeyHJQILFPVRNHTIG-UHFFFAOYSA-N
SynonymCS-7936 | MU3JD8E9IS | s8321 | 5-(3-methylphenoxy)-2(1h)-pyrimidinone | HMS3749I15 | AS-16416 | SMR004704144 | GTPL9433 | 5-(m-tolyloxy)pyrimidin-2(1H)-one | NSC-314335 | TOLIMIDONE | NSC314335 | 5-(m-Tolyloxy)-2(1H)-pyrimidinone | A899682 | AC-37077 | BD
CAS No.41964-07-2
PubChem CID39065

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H319
Precautionary Statement(s)
P305+P351+P338

Synthetic Route by SureRoute

1. ACIVQY671 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACIVQY671 route product structure diagram
    ACIVQY67141964-07-2 In Stock
Inquiry

2. ACIVQY671 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACBHXW019 route compound structure diagram
    ACBHXW019214290-49-0 In Stock
  4. Then
  5. ACIVQY671 route product structure diagram
    ACIVQY67141964-07-2 In Stock
Inquiry

Comments (0)